XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Share Owners' Equity
3 Months Ended
Mar. 31, 2025
Share Owners' Equity  
Share Owners' Equity

11. Share Owners’ Equity

The activity in share owners’ equity for the three months ended March 31, 2025 and 2024 is as follows:

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

 

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

Balance on January 1, 2025

$

2

$

3,053

(677)

$

676

$

(1,975)

$

126

$

1,205

Reissuance of common stock (0.2 million shares)

(2)

5

 

3

Shares repurchased (0.9 million shares)

(10)

 

(10)

Stock compensation (1.3 million shares)

4

 

4

Net earnings (loss)

(16)

4

 

(12)

Other comprehensive income (loss)

61

5

 

66

Other

(7)

 

(7)

Balance on March 31, 2025

$

2

$

3,045

$

(679)

$

660

$

(1,914)

$

135

$

1,249

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

    

Stock

    

Par Value

    

Stock

Earnings

Loss

Interests

Equity

 

Balance on January 1, 2024

$

2

$

3,086

$

(681)

$

782

$

(1,580)

$

135

$

1,744

Reissuance of common stock (0.2 million shares)

(2)

5

 

3

Shares repurchased (0.6 million shares)

(10)

(10)

Stock compensation (1.9 million shares)

7

 

7

Net earnings

72

4

 

76

Other comprehensive income (loss)

20

 

20

Other

(14)

(14)

Balance on March 31, 2024

$

2

$

3,081

$

(690)

$

854

$

(1,560)

$

139

$

1,826

During the three months ended March 31, 2025, the Company purchased 941,274 shares of its common stock for approximately $10 million. The share purchases were made pursuant to a $100 million anti-dilutive share repurchase program authorized by the Company’s Board of Directors on May 14, 2024, which is intended to offset stock-based compensation provided to the Company’s directors, officers, and employees. Approximately $70 million remained available for purchases under this program as of March 31, 2025.

The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:

Shares Outstanding (in thousands)

 

March 31,

December 31,

March 31,

 

    

2025

    

2024

    

2024

 

Shares of common stock issued (including treasury shares)

 

185,824

184,851

187,083

Treasury shares

 

31,141

30,784

31,361